# Impact of Metformin on Leptin Transport in Cerebrospinal Fluid of Obese Patients

> **NCT03974139** · PHASE2 · UNKNOWN · sponsor: **Lille Catholic University** · enrollment: 31 (estimated)

## Conditions studied

- Obesity Without Type 2 Diabetes, With BMI>30

## Interventions

- **DRUG:** Metformin Oral Tablet

## Key facts

- **NCT ID:** NCT03974139
- **Lead sponsor:** Lille Catholic University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-03
- **Primary completion:** 2024-06-15
- **Final completion:** 2024-09-30
- **Target enrollment:** 31 (ESTIMATED)
- **Last updated:** 2023-10-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03974139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03974139, "Impact of Metformin on Leptin Transport in Cerebrospinal Fluid of Obese Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03974139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*